Associate Professor Bismuth received his medical degree from Copenhagen University in Copenhagen, Denmark and completed his surgical residency at The Brooklyn Hospital Center. Subsequently, he completed his Vascular Fellowship at Baylor College of Medicine in Houston.
Dr Bismuth is the recipient of a Society for Vascular Surgery grant and is a national PI for two major clinical trials in the US. He is also the recipient of the Dyer Fellowship Award to support his research in vascular surgery robotics, and imaging and computational fluid dynamics.
Dr Bismuth comes to us to share his knowledge and expertise in the areas of complex/junctional
aortic aneurysm management, iliac and infrainguinal occlusive disease. He is heavily involved in the training of US Vascular and Endovascular surgeons and will provide insight into their programs and ideas. He has collaborated with industry to bring ideas to life and will guide us on how we can all collaborate further with industry to improve outcomes for patients.
Dr Bismuth is a very exciting addition to the ANZSVS 2019 program with much to offer the society.
Appointed Consultant Vascular Surgeon and Director of Trauma Royal Victoria Hospital Belfast in 1995 he stepped down as Trauma Director in 2012 to become Clinical Director of the regional vascular unit in Belfast following the reconfiguration of vascular services in Northern Ireland .The unit serves a population of 1.8 million and is the highest volume centre in the UK for AAA, Carotid and lower limb revascularisation procedures.
He currently undertakes all index vascular cases but has a special interest in carotid body tumours and lower limb revascularisation.
In 2014/15 he was elected President of the Vascular Society of Great Britain and is currently chair of the Professional Standards Committee of VSGBI.
He has been actively involved in the reconfiguration of vascular services throughout the UK and Ireland and has chaired a number of professional and service reviews on behalf of VSGBI and the Royal College of Surgeons London.
Reconfiguration of vascular services can be problematic for a variety of reasons and significant lessons have been learned by all concerned in this process of moving towards a smaller number of high volume arterial centres.
Miguel Montero-Baker, M.D. is an associate professor in the Division of Vascular Surgery and Endovascular Therapy in Houston, Texas specializing in Diabetic Foot Amputation Prevention and Limb Salvage. Dr Montero-Baker graduated with honours both from medical school and his residency in Vascular Surgery at the University of Costa Rica. After his residency training, he was awarded a DAAD (German Academic Exchange Service) scholarship to further pursue his interest in interventional therapies in Leipzig, Germany and completed a peripheral vascular ultrasound fellowship, as well as an advanced peripheral endovascular interventions fellowship. Driven by his passion for research and development of new diagnostic techniques for ischemic limbs, Dr Montero-Baker completed an Integrated Vascular Surgery Residency at the University of Arizona and went on to join the faculty as an assistant professor.
Dr Montero-Baker is author of numerous journal publications, has co-authored several textbook chapters and is a well-recognized opinion leader for the Latin American medical community. Dr Montero-Baker’s main clinical interests are critical limb ischemia, implantable micro-technology and endovascular carotid disease management.
He is an active member of the Society for Vascular Surgery, the International Society for Vascular Surgery, the International Society of Endovascular Surgeons, Endovascular Surgeons of Latin America and the Latin America Society of Vascular Surgeons.
Dr. Rhee is an international leader in the treatment of complex aortic diseases. He has extensive experience in both direct surgical and endovascular management of complex abdominal, thoracic and thoracoabdominal aortic aneurysms and dissections. He has been involved with and has led significant vascular device trials since 1995 and continues to bring “state of the art” technologies to his patients by offering the latest minimally invasive treatment options not generally offered at most local hospitals, including: fenestrated and branched graft aortic endovascular repair. He is the director of the Maimonides Medical Center Aortic Center.
His major areas of treatment expertise include:
Abdominal aortic aneurysm (AAA) Thoracic aortic aneurysm (TAA) Thoracoabdominal aortic aneurysm (TAAA) Acute and chronic aortic dissections Carotid artery stenosis and stroke Peripheral arterial disease (PAD)
Dr. Rhee has published over 100 articles in leading journals and textbooks on the topic of vascular disease. He has lectured in over a dozen countries, while serving on and leading various national committees in the Society for Vascular Surgery, Eastern Vascular Surgery, and the Society for Clinical Vascular Surgery. He serves as both the institutional and national lead investigator of several clinical research trials.